High Accuracy Stool Biomarkers of Precancerous Colorectal Cancer Identified Using a 2000-Plex Immunoproteomic Screen
Open Access
- 1 October 2025
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (3) , 101079
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01CA086400)
This publication has 52 references indexed in Scilit:
- Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancerJournal of Gastroenterology, 2021
- US Preventive Services Task Force Recommendations for Colorectal Cancer ScreeningJAMA, 2021
- Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and LocationClinical Gastroenterology and Hepatology, 2020
- miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT processMolecular and Cellular Biochemistry, 2020
- Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progressionThe Journal of Pathology, 2019
- Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecanCancer Chemotherapy and Pharmacology, 2019
- Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal CancerJournal of Gastrointestinal Cancer, 2018
- Colorectal Cancer Disparity in African AmericansThe American Journal of Pathology, 2018
- The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference?Digestive Diseases and Sciences, 2015
- Matrix Metalloproteinase-9 Expression in the Normal Mucosa–Adenoma–Dysplasia–Adenocarcinoma Sequence of the ColonPathology and Oncology Research, 2008